Similar articles

Abstract: spinal cord injury (SCI) causes motor, sensory, and autonomic dysfunctions. The gut microbiome has an important role in SCI, while short-chain fatty acids (SCFAs) are one of the main bioactive mediators of microbiota. In the present study, we explored the effects of oral administration of exogenous SCFAs on the recovery of locomotor function and tissue repair in SCI. Allen’s method was utilized to establish an SCI model in Sprague-Dawley (SD) rats. The animals received water containing a mixture of 150 mmol/L SCFAs after SCI. After 21 d of treatment, the Basso, Beattie, and Bresnahan (BBB) score increased, the regularity index improved, and the base of support (BOS) value declined. Spinal cord tissue inflammatory infiltration was alleviated, the spinal cord necrosis cavity was reduced, and the numbers of motor neurons and Nissl bodies were elevated. Enzyme-linked immunosorbent assay (ELISA), real-time quantitative polymerase chain reaction (qPCR), and immunohistochemistry assay revealed that the expression of interleukin (IL)‍-10 increased and that of IL-17 decreased in the spinal cord. SCFAs promoted gut homeostasis, induced intestinal t cells to shift toward an anti-inflammatory phenotype, and promoted regulatory T (Treg) cells to secrete IL-10, affecting Treg cells and IL-17⁺ γ;δ; t cells in the spinal cord. Furthermore, we observed that Treg cells migrated from the gut to the spinal cord region after SCI. The above findings confirm that SCFAs can regulate Treg cells in the gut and affect the balance of Treg and IL-17⁺ γ;δ; t cells in the spinal cord, which inhibits the inflammatory response and promotes the motor function in SCI rats. Our findings suggest that there is a relationship among gut, spinal cord, and immune cells, and the “gut-spinal cord-immune” axis may be one of the mechanisms regulating neural repair after SCI.

短链脂肪酸通过调节调节性T细胞和IL-17⁺ γδ T细胞的平衡来改善脊髓损伤的恢复

[1]AllenAR, 1911. Surgery of experimental lesion of spinal cord equivalent to crush injury of fracture dislocation of spinal column: a preliminary report. JAMA, LVII(11):878-880.

[2]BassoDM, BeattieMS, BresnahanJC, 1995. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma, 12(1):1-21.

[3]BassoDM, BeattieMS, BresnahanJC, et al., 1996. Mascis evaluation of open field locomotor scores: effects of experience and teamwork on reliability. J Neurotrauma, 13(7):343-359.

[4]BazzocchiG, TurroniS, BulzaminiMC, et al., 2021. Changes in gut microbiota in the acute phase after spinal cord injury correlate with severity of the lesion. Sci Rep, 11:12743.

[5]BenakisC, BreaD, CaballeroS, et al., 2016. Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδ T cells. Nat Med, 22(5):516-523.

[6]BezkorovainyA, 2001. Probiotics: determinants of survival and growth in the gut. Am J Clin Nutr, 73(2):399S-405S.

[7]CerviAL, LukewichMK, LomaxAE, 2014. Neural regulation of gastrointestinal inflammation: role of the sympathetic nervous system. Auton Neurosci, 182:83-88.

[8]DoddW, MotwaniK, SmallC, et al., 2022. Spinal cord injury and neurogenic lower urinary tract dysfunction: what do we know and where are we going? J Mens Health, 18(1):24.

[9]EliI, LernerDP, GhogawalaZ, 2021. Acute traumatic spinal cord injury. Neurol Clin, 39(2):471-488.

[10]FerreiraTM, LeonelAJ, MeloMA, et al., 2012. Oral supplementation of butyrate reduces mucositis and intestinal permeability associated with 5-fluorouracil administration. Lipids, 47(7):669-678.

[11]GungorB, AdiguzelE, GurselI, et al., 2016. Intestinal microbiota in patients with spinal cord injury. PLoS ONE, 11(1):e0145878.

[12]HeJ, ZhaoJ, PengX, et al., 2017. Molecular mechanism of miR-136-5p targeting NF-κB/A20 in the IL-17-mediated inflammatory response after spinal cord injury. Cell Physiol Biochem, 44(3):1224-1241.

[13]HillF, KimCF, GorrieCA, et al., 2011. Interleukin-17 deficiency improves locomotor recovery and tissue sparing after spinal cord contusion injury in mice. Neurosci Lett, 487(3):363-367.

[14]HuangR, LiuP, BaiYG, et al., 2022. Changes in the gut microbiota of osteoporosis patients based on 16S rRNA gene sequencing: a systematic review and meta-analysis. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 23(12):‍1002-1013.

[15]HuuskonenJ, SuuronenT, NuutinenT, et al., 2004. Regulation of microglial inflammatory response by sodium butyrate and short-chain fatty acids. Br J Pharmacol, 141(5):874-880.

[16]JingYL, YuY, BaiF, et al., 2021a. Effect of fecal microbiota transplantation on neurological restoration in a spinal cord injury mouse model: involvement of brain-gut axis. Microbiome, 9:59.

[17]JingYL, BaiF, YuY, 2021b. Spinal cord injury and gut microbiota: a review. Life Sci, 266:118865.

[18]JogiaT, RuitenbergMJ, 2020. Traumatic spinal cord injury and the gut microbiota: current insights and future challenges. Front Immunol, 11:704.

[19]KigerlKA, HallJCE, WangLL, et al., 2016. Gut dysbiosis impairs recovery after spinal cord injury. J Exp Med, 213(12):2603-2620.

[20]KigerlKA, MostacadaK, PopovichPG, 2018. Gut microbiota are disease-modifying factors after traumatic spinal cord injury. Neurotherapeutics, 15(1):60-67.

[21]LaneG, GracelyA, BassisC, et al., 2022. Distinguishing features of the urinary bacterial microbiome in patients with neurogenic lower urinary tract dysfunction. J Urol, 207(3):627-634.

[22]LuYT, LiuHY, YangK, et al., 2022. A comprehensive update: gastrointestinal microflora, gastric cancer and gastric premalignant condition, and intervention by traditional Chinese medicine. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 23(1):1-18.

[23]LucasS, OmataY, HofmannJ, et al., 2018. Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss. Nat Commun, 9:55.

[24]MattSM, AllenJM, LawsonMA, et al., 2018. Butyrate and dietary soluble fiber improve neuroinflammation associated with aging in mice. Front Immunol, 9:1832.

[25]MichelM, GoldmanM, PeartR, et al., 2021. Spinal cord injury: a review of current management considerations and emerging treatments. J Neurol Sci Res, 2(2):14.

[26]MoriyamaM, NishimuraY, KurebayashiR, et al., 2021. Acetate suppresses lipopolysaccharide-stimulated nitric oxide production in primary rat microglia but not in BV-2 microglia cells. Curr Mol Pharmacol, 14(2):253-260.

[27]NakamuraYK, JanowitzC, MeteaC, et al., 2017. Short chain fatty acids ameliorate immune-mediated uveitis partially by altering migration of lymphocytes from the intestine. Sci Rep, 7:11745.

[28]O'ConnorG, JeffreyE, MadormaD, et al., 2018. Investigation of microbiota alterations and intestinal inflammation post-spinal cord injury in rat model. J Neurotrauma, 35(18):2159-2166.

[29]ParkJ, KimM, KangSG, et al., 2015. Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunol, 8(1):80-93.

[30]ParkJ, GoergenCJ, HogeneschH, et al., 2016. Chronically elevated levels of short-chain fatty acids induce T cell-mediated ureteritis and hydronephrosis. J Immunol, 196(5):2388-2400.

[31]PatnalaR, ArumugamTV, GuptaN, et al., 2017. HDAC inhibitor sodium butyrate-mediated epigenetic regulation enhances neuroprotective function of microglia during ischemic stroke. Mol Neurobiol, 54(8):6391-6411.

[32]RamosMG, BambirraEA, CaraDC, et al., 1997. Oral administration of short-chain fatty acids reduces the intestinal mucositis caused by treatment with Ara-C in mice fed commercial or elemental diets. Nutr Cancer, 28(2):212-217.

[33]RatajczakW, RylA, MizerskiA, et al., 2019. Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs). Acta Biochim Pol, 66(1):1-12.

[34]SilvaYP, BernardiA, FrozzaRL, 2020. The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front Endocrinol (Lausanne), 11:25.

[35]StephensonJ, NutmaE, van der ValkP, et al., 2018. Inflammation in CNS neurodegenerative diseases. Immunology, 154(2):204-219.

[36]SunGD, YangSX, CaoGC, et al., 2018. γδ T cells provide the early source of IFN-γ to aggravate lesions in spinal cord injury. J Exp Med, 215(2):521-535.

[37]TateDG, ForchheimerM, RodriguezG, et al., 2016. Risk factors associated with neurogenic bowel complications and dysfunction in spinal cord injury. Arch Phys Med Rehabil, 97(10):1679-1686.

[38]ValidoE, BertoloA, FranklGP, et al., 2022. Systematic review of the changes in the microbiome following spinal cord injury: animal and human evidence. Spinal Cord, 60(4):288-300.

[39]WallaceDJ, SayreNL, PattersonTT, et al., 2019. Spinal cord injury and the human microbiome: beyond the brain-gut axis. Neurosurg Focus, 46(3):E11.

[40]XuP, ZhangF, ChangMM, et al., 2021. Recruitment of γδ T cells to the lesion via the CCL2/CCR2 signaling after spinal cord injury. J Neuroinflammation, 18:64.

[41]YuBB, QiuHD, ChengSP, et al., 2021. Profile of gut microbiota in patients with traumatic thoracic spinal cord injury and its clinical implications: a case-control study in a rehabilitation setting. Bioengineered, 12(1):4489-4499.

[42]ZhangJX, XieQS, KongWM, et al., 2020. Short-chain fatty acids oppositely altered expressions and functions of intestinal cytochrome P4503A and P-glycoprotein and affected pharmacokinetics of verapamil following oral administration to rats. J Pharm Pharmacol, 72(3):448-460.